Skip to main content

Zenas BioPharma, Inc.

corporate_fare Company Profile

Zenas BioPharma, Inc.

Zenas BioPharma, Inc., a clinical-stage biopharmaceutical company, engages in the development and commercialization of transformative immunology-based therapies. Its lead product candidate is obexelimab, a bifunctional monoclonal antibody designed to bind CD19 and Fc?RIIb for the treatment of various I&I diseases and various indications, including immunoglobulin G4-related disease, multiple sclerosis, and systemic lupus erythematosus. The company also develops ZB002, an anti-TNFa monoclonal antibody; ZB004, a cytotoxic T-lymphocyte-associated antigen 4-immunoglobulin fusion; and ZB001, an anti-IGF-1R monoclonal antibody. The company was formerly known as Zenas BioPharma (Cayman) Limited and changed its name to Zenas BioPharma, Inc. in August 2023. The company was incorporated in 2019 and is headquartered in Waltham, Massachusetts.

Exchange: NASDAQSector: Life Sciences

show_chartPrice Chart

Loading chart...

feed ZBIO - Latest Insights

ZBIO
Apr 02, 2026, 5:44 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
ZBIO
Apr 01, 2026, 4:30 PM EDT
Filing Type: 4
Importance Score:
8
ZBIO
Mar 31, 2026, 5:00 PM EDT
Filing Type: 4
Importance Score:
7
ZBIO
Mar 31, 2026, 4:35 PM EDT
Filing Type: 8-K
Importance Score:
8
ZBIO
Mar 30, 2026, 9:20 AM EDT
Filing Type: 424B5
Importance Score:
8
ZBIO
Mar 30, 2026, 9:18 AM EDT
Filing Type: 424B5
Importance Score:
8
ZBIO
Mar 27, 2026, 12:03 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
ZBIO
Mar 27, 2026, 6:04 AM EDT
Filing Type: FWP
Importance Score:
8
ZBIO
Mar 27, 2026, 6:00 AM EDT
Filing Type: FWP
Importance Score:
8
ZBIO
Mar 27, 2026, 12:12 AM EDT
Source: GlobeNewswire
Importance Score:
8
ZBIO
Mar 26, 2026, 4:31 PM EDT
Filing Type: 424B5
Importance Score:
8
ZBIO
Mar 26, 2026, 4:29 PM EDT
Filing Type: 424B5
Importance Score:
8
ZBIO
Mar 26, 2026, 4:10 PM EDT
Filing Type: FWP
Importance Score:
7
ZBIO
Mar 26, 2026, 4:01 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
ZBIO
Mar 16, 2026, 7:26 AM EDT
Filing Type: 10-K
Importance Score:
8
ZBIO
Mar 16, 2026, 7:17 AM EDT
Filing Type: 8-K
Importance Score:
9
ZBIO
Jan 14, 2026, 4:30 PM EST
Filing Type: SCHEDULE 13D
Importance Score:
7
ZBIO
Jan 09, 2026, 9:42 PM EST
Filing Type: 4
Importance Score:
7
ZBIO
Jan 05, 2026, 7:16 AM EST
Filing Type: 8-K
Importance Score:
9